The company has received the Certificate of GMP Compliance from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
The expansion makes Exothera one of the largest viral vector facilities in Europe
The facility will manufacture its Herceptin biosimilar, Tuznue
The GMP certificate is valid for three years until April 2024.
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
he inspection covering the sterile drug product filling and packaging line, quality systems and quality control laboratories concluded compliance with the principles and guidelines of Good Manufacturing Practice
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
The site’s GMP Certification has been successfully renewed
Subscribe To Our Newsletter & Stay Updated
